Down We Go?
Yesterday, we discussed how the market had shown relative strength recently and asked the question whether the bullish sentiment would last. While it’s hard to know precisely when a bottom will take place, we highlighted the danger of trying to pick the low point because inevitably at some stage betting on the bottom will lead to a losing trade where lower lows follow. » Read more about: Down We Go? »
Read More
Market Crash to Start NOW?
When the market crashed in 2020, COVID was cited as the cause. A contagious virus was contaminating people across the globe. Businesses were shut down. In some nations, travel restrictions extended to being unable to drive more than 3 miles without encountering checkpoints. In anticipation of a global collapse of enterprise and transactions of goods and services,
» Read more about: Market Crash to Start NOW? »
Read More
AI Stock Finally Turns Profitable: Buy, Buy, Buy?
It’s been a brutal twelve months for Palantir shareholders with the stock dropping 34.9%. But on Valentine’s Day loyal shareholders finally were rewarded with good news that spiked PLTR share price by 21.1% after the company reported profit of a single penny per share in Q4 (a loss of $0.03 was expected). Better yet, the company forecast a profitable 2023.
» Read more about: AI Stock Finally Turns Profitable: Buy, Buy, Buy? »
Read More
Billionaire Bets 30% On 1 Weird Stock
Nelson Peltz is a billionaire whose net worth is estimated at $1.7 billion. We took a deep dive into his portfolio and found an astonishing finding. He bet over 30% of his portfolio on a single stock, a plumbing and heating products distributor.
Read More
Is This Little-Known Health Innovation The Next Big Thing?
It’s hard to find the next big thing but Exact Sciences might be as close as any company is to it via its liquid biopsies, a transformative approach to diagnosing and monitoring various diseases by detecting signs of cancer, genetic anomalies, or other conditions in blood or other bodily fluids.
This technology has been particularly promising for cancer,
» Read more about: Is This Little-Known Health Innovation The Next Big Thing? »
Read MoreThe Burst
Got $1,780? Is This The Best Investment In 2024?
Retail investors are conditioned to focus on gains but those who have been around the block and made a fortune focus first on downside risks.
That focus is one of the reasons why so many buy Berkshire Hathaway. After all, when the stock market fell by 20% in 2022, Berkshire treaded water and essentially stayed flat.
» Read more about: Got $1,780? Is This The Best Investment In 2024? »
Read MoreThe Spotlight
Billionaire Bets 16.1% of Portfolio on 1 Energy Stock
Billionaire David Tepper has taken big stakes in some of the best known companies on earth. He’s bet 14.1% of his portfolio on Alphabet, 12.0% of it on Amazon, and 8.7% on Meta. Surprisingly though, none of those tech bellwethers eclipse his top holding in a single energy company, Constellation Energy. He’s put an astonishing 16.1% of his portfolio into this one energy stock,
» Read more about: Billionaire Bets 16.1% of Portfolio on 1 Energy Stock »
Read More